data processing system class-vp version 6.13 (Shimadzu Corporation)
90
Structured Review
Shimadzu Corporation
data processing system class-vp version 6.13
Data Processing System Class Vp Version 6.13, supplied by Shimadzu Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/data+processing+system+class-vp+version+6%2E13/uv+vis+spectrophotomet/pm24886771-33-23-29
Average 90 stars, based on 1 article reviews
Data Processing System Class Vp Version 6.13, supplied by Shimadzu Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/data+processing+system+class-vp+version+6%2E13/uv+vis+spectrophotomet/pm24886771-33-23-29
Average 90 stars, based on 1 article reviews
data processing system class-vp version 6.13 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Determination of duloxetine in human plasma with proven lack of influence of the major metabolite 4-hydroxyduloxetine. Article Snippet: Clinical Biochemistry xxx (2014) xxx–xxx CLB-08765; No. of pages: 3; 4C: Contents lists available at ScienceDirect Clinical Biochemistry j ourna l homepage: www.e lsev ie r .com/ locate /c l inb iochem Short Communication Determination of duloxetine in human plasma with proven lack of influence of the major metabolite 4-hydroxyduloxetine Michał Kaza a,⁎, Edyta Gilant a, Monika Filist a,b, Iwona Szlaska b, Tomasz Pawiński b, Piotr J. Rudzki a a Pharmaceutical Research Institute, Pharmacology Department, 8 Rydygiera, 01-793 Warsaw, Poland b Medical University of Warsaw, Department of Drug Chemistry, 1 Banacha, 02-097 Warsaw, Poland Abbreviations: 4-OH-D-Gluc, 4-hydroxyduloxetine gl Medicines Agency; IS, internal standard; LLOQ, lower lim of reaching maximum plasma concentration; HPLC, highraphy; QC samples, quality control samples; UV, ultraviol ⁎ Corresponding author at: Pharmaceutical Research Warsaw, Poland.. Fax: +48 22 456 38 38.. E-mail address: m.kaza@ifarm.eu (M. Kaza). http://dx.doi.org/10.1016/j.clinbiochem.2014.05.059 0009-9120/© 2014 The Canadian Society of Clinical Chem Please cite this article as: Kaza M., et al., Dete hydroxyduloxetine, Clin Biochem (2014), ht a b s t r a c t a r t i c l e i n f o |